Cheryann (Cher) Huether
St Louis,MO
Summary
Passionate, award-winning Executive Customer Sales Representative with over 25 years of exceptional pharmaceutical sales experience. Proven ability to effectively manage multiple product lines and develop strategies to attain and surpass sales goals in a changing market. Numerous awards and recognitions for sales performance and leadership. Able to build relationships, establish credibility and maintain excellent rapport within accounts.
Overview
25
25
years of professional experience
Work History
Executive Sales Representative
Merck & Company, U.S. Human Health
04.2018 - Current
Successfully launched, grew, and maintained multi-million dollar product line in the St. Louis territory. Promoted/Launched in Diabetes, Respiratory, Insomnia, and Cardiovascular Market with promotions/presentations to Primary Care physicians, Internal Medicine, Pediatrics, Allergists, Pulmonologists, Endocrinologist, Cardiologists, ENTs, Medical Directors, Pharmacy Directors, Pharmacists, Hospitalists, Nurse Practitioners, and Nurses. Launched Steglatro and Verquvo. Maintained and grew Januvia, Janumet, Dulera, Asmanex, and Belsomra.
*#1 Belsomra market share change in Region 2023. Tops in District 2021
*Top in District launch with Verquvo 2021
*Ways of Working Award 2020. Successful in-person to-virtual transition
*Directors Award 2019 top 10% across portfolio line
*#1 in district, top in region Diabetes share change 2018/2019
*Lead District and top 20% in region Steglatro share/share change 2019/2020
*Lead district in top planning metrics in district 2018-2023
*Over 127 separate Inspire awards given since 2018 for Grit, teamwork, persistence, Axonify leadership, accuracy, attention to detail, compliance point, Ace (Digital footprint)
Senior Customer Sales Representative
Merck & Company, U.S. Human Health
03.2003 - 03.2018
Successfully met and exceeded sales goals in Diabetes, Cardiovascular and Respiratory markets. Launched: Vytorin, Singulair AR, Dulera. Promoted: Zetia, Singulair, Januvia, Vioxx, Nasonex, Asmanex, Zostavax & Avelox.
*Led and Facilitated multiple disease-focus programs
*Directors award top 10% across product line 2005, 2009, 2011 (Top launch in region Dulera)
*Award of Excellence for Leadership 2003, 2004, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2015, 2017
*#1 Diabetes Portfolio in District, top 10 in region 2016
*National recognition "Raise your Game" Diabetes market share change 2017
*Triple S Hall of Famer top 10% market share for Singulair 2003/04. Ranked #1 (98 territories)
*Multiple top 20% awards and recognition across product line
Professional Representative 1 & 2
Merck & Company, U.S. Human Health
02.1999 - 03.2003
Successfully Launched and exceeded sales goals. Launched Vioxx, Zetia. Promoted: Singulair, Fosamax, Zocor, Pepcid and Propecia.
*Top 10% award 2002 106% all products. #1 in district #3 in nation
*Highest share/share change Singulair in Nation 2001
*#1 PPO Kansas City Region (over 98 territories) 122% 2000
Education
Bachelor of Arts - Media Communications/Business Marketing
Webster University
St. Louis, MOSkills
- Customer Engagement
- Customer research & analysis
- Product Launch/Growth
- Goal oriented-results driven
- Client retention
- Relationship building
- Self-motivated
- Account management
- Obstacle/Problem solving
- Sales Presentations
- Multitasking
- Effective communication
Timeline
Executive Sales Representative
Merck & Company, U.S. Human Health
04.2018 - Current
Senior Customer Sales Representative
Merck & Company, U.S. Human Health
03.2003 - 03.2018
Professional Representative 1 & 2
Merck & Company, U.S. Human Health
02.1999 - 03.2003
Bachelor of Arts - Media Communications/Business Marketing
Webster University
Similar Profiles
AUSTIN GULLOAUSTIN GULLO
Associate Director, US Oncology | CDL, Lung HCP at Merck & Co, U.S. Human HealthAssociate Director, US Oncology | CDL, Lung HCP at Merck & Co, U.S. Human Health
Tevin WarrenTevin Warren
Senior Health Communications Specialist (GS-14) at U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary of Health (OASH), Office of Infectious Disease and HIV/AIDS Policy (OIDP)Senior Health Communications Specialist (GS-14) at U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary of Health (OASH), Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Constance T. DavisConstance T. Davis
OPEC OPC Program Analyst at U.S. Department of Human Health Services Food Drug AdministrationOPEC OPC Program Analyst at U.S. Department of Human Health Services Food Drug Administration
Sydney HalbachSydney Halbach
CCMA at Barnes Jewish HospitalCCMA at Barnes Jewish Hospital
Mark HanesMark Hanes
Plan Advisor at UMRPlan Advisor at UMR